MARTINA FEE: Open Payments
NPI 1821051475 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 28 payments from 16 companies in 2025. Trend: 2023 $468 · 2024 $497 · 2025 $611
Food & beverage: $611Education: $0
| Company | Payments | Amount |
|---|---|---|
| Vifor Pharma, Inc. | 3 | $100 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Ardelyx, Inc. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Fresenius USA Marketing, Inc. | 3 | $48 |
| Calliditas Therapeutics US Inc. | 2 | $39 |
| Amgen Inc. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| AKEBIA THERAPEUTICS INC | 1 | $28 |
| Apellis Pharmaceuticals, Inc. | 1 | $26 |
Products named: Veltassa, IBSRELA, JYNARQUE, FARXIGA, VELPHORO, TARPEYO, TAVNEOS, Fabhalta.
Industry payments across KY — which companies pay providers there.
